silvio inzucchi, md: implications of initial egfr response to empagliflozin
Published 4 years ago • 945 plays • Length 8:35
Download video MP4
Download video MP3
Similar videos
-
11:02
silvio inzucchi, md: dapagliflozin reduces new-onset diabetes
-
5:43
silvio e inzucchi, md
-
28:29
heart-friendly glucose lowering regimens in type 2 diabetes - dr. silvio e. inzucchi
-
7:34
designing better cardiovascular outcomes trials in diabetes
-
1:03:28
6/15/18: diabetes & cvd: have we found the holy grail?
-
4:02
modifying diabetes drug therapy in the presence of renal disease
-
11:52
safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease
-
22:20
diabetes medications - sglt 2 inhibitors - empagliflozin and metformin (synjardy)
-
6:43
diabetes insipidus endocrinology made easy with medical animation video
-
6:22
an overview of cardiovascular outcome trials (cvots) in type 2 diabetes
-
5:19
considerations for basal or bolus insulin in diabetes
-
3:36
diabetes insipidus: learn it fast remember it forever!(step 1, comlex, nclex®, pance, aanp)
-
9:21
diabetes insipidus - causes, symptoms, diagnosis, treatment, pathology
-
44:35
efl042 - synergistic effects of glp-1 ras and exercise
-
2:36
steve nissen, md: sglt-2 inhibitors, then & now
-
0:58
diabetes insipidus - one of the most feared high yields
-
3:08
what is diabetes?
-
16:10
how sglt-2 inhibitors work: with pros and cons - jardiance, farxiga, invokana -type 2 diabetes#15
-
4:30
siadh vs diabetes insipidus
Clip.africa.com - Privacy-policy